Niveau de preuve du suivi thérapeutique pharmacologique du méthotrexate au décours de son administration à haute-dose
Therapie, 65 3 (2010) 163-169
Published online: 2010-08-11
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Predictive factors for delayed high-dose methotrexate elimination: A practical issue for diffuse large B-cell lymphoma patients
Margot Vattaire-Hervé, Antoine Le Bozec, Justine Clarenne, Guillaume Cohet, Violaine Lepage, Chloé Gossery, Elise Michelet-Huot, Anne Quinquenel, Isabelle Madelaine, Eric Durot and Florian SlimanoJournal of Oncology Pharmacy Practice (2025)
https://doi.org/10.1177/10781552251340000
The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review
Wissal Chellal, Youssra Metarfi, Zineb Ben Khadda, Hasnae Hoummani, Rhizlane Berrady and Sanae AchourSeminars in Oncology 52 (2) 152342 (2025)
https://doi.org/10.1016/j.seminoncol.2025.152342
Real-Time, Seconds-Resolved Measurements of Plasma Methotrexate In Situ in the Living Body
Alejandro Chamorro-Garcia, Julian Gerson, Charlotte Flatebo, Lisa Fetter, Alex M. Downs, Nicole Emmons, Herbert L. Ennis, Nenad Milosavić, Kyungae Yang, Milan Stojanovic, Francesco Ricci, Tod E. Kippin and Kevin W. PlaxcoACS Sensors 8 (1) 150 (2023)
https://doi.org/10.1021/acssensors.2c01894
Suivi thérapeutique pharmacologique du méthotrexate à haute dose
B. Royer, S. Bouchet, L. Goldwirt, J.-B. Woillard and P. MarquetEMC - Biologie Médicale 16 (2) 1 (2021)
https://doi.org/10.1016/S2211-9698(21)43174-2
Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate
Nicolas Fabresse, Bénédicte Devictor, Christel Pissier, et al.Therapeutic Drug Monitoring 40 (1) 76 (2018)
https://doi.org/10.1097/FTD.0000000000000445
A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy
Régis Bouquié, Guillaume Deslandes, Blanca Nieto Bernáldez, et al.Anal. Methods 6 (1) 178 (2014)
https://doi.org/10.1039/C3AY40815A
A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy
Régis Bouquié, Guillaume Deslandes, Blanca Nieto Bernáldez, et al.Analytical Methods 6 (1) 178 (2014)
https://doi.org/10.1039/c3ay40815a
Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor
Sandy Shuo Zhao, Mathilde A. Bichelberger, Damien Y. Colin, et al.The Analyst 137 (20) 4742 (2012)
https://doi.org/10.1039/c2an35839e
Evidence for Therapeutic Drug Monitoring of Targeted Anticancer Therapies
Bo Gao, Shang Yeap, Arthur Clements, Bavanthi Balakrishnar, Mark Wong and Howard GurneyJournal of Clinical Oncology 30 (32) 4017 (2012)
https://doi.org/10.1200/JCO.2012.43.5362
Suivi thérapeutique pharmacologique du méthotrexate à faible dose dans les maladies inflammatoires
Marie-Clémence Verdier, Olivier Tribut, Sophie Bodeau, Dorothée Rihouey and Danièle Bentué-FerrerThérapie 66 (1) 63 (2011)
https://doi.org/10.2515/therapie/2011002
Conseil et éducation pour un patient souffrant de polyarthrite rhumatoïde
F. LagrangeLe Pharmacien Hospitalier et Clinicien 46 (2) 123 (2011)
https://doi.org/10.1016/j.phclin.2011.05.012